292949
Importance of institutional arrangements in translating aging research into policy and practice: Findings from a cross-country survey in the arab world
Methods A cross-country mapping survey on aging policies and programs was conducted for 20 Arab countries in 2012. Drawing on the Madrid Plan of Action on Aging guidelines and the recent WHO Knowledge Translation on Ageing and Health publication, composite scores were generated for knowledge creation (e.g. research networks/reports/studies ..), institutional arrangements (e.g. departments/national committees …), and knowledge translation (e.g. policy briefs, linkages efforts …). Due to a large proportion of missing data, four countries were excluded from the analysis.
Results The Arab region scored highest in knowledge creation (5.8), followed by institutional arrangements (4.6) and least in knowledge translation (2.9). Bivariate analysis showed that both knowledge creation and institutional arrangements significantly correlate with knowledge translation (correlation coefficient 0.63, p-value 0.009; 0.79, p-value <0.001, respectively). However, in multivariate analysis and controlling for Human Development Index, only institutional arrangements retained significant association with knowledge translation (p-value 0.04).
Conclusions These preliminary results underscore the value of institutional arrangements and political commitment in catalyzing the translation of aging research into policy and practice.
Learning Objectives:
List the indicators used to generate composite scores for knowledge creation, institutional arrangements and knowledge translation.
Discuss the value of institutional arrangements and political commitment in translating aging research into policy and practice.
Qualified on the content I am responsible for because: I have been a project coordinator of the 2012 mapping of policies and programs on aging in the Arab world.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.